Sort
11,323 grants matching “glioblastoma”
Therapeutic targeting of multiple glioblastoma phagocytosis checkpoints using a novel bispecific antibody
$444,583Wen Jiang · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · NS
Spherical Nucleic Acid nano-architectures as first-in-class cGAS agonists for the immunotherapeutic treatment of Glioblastoma.
$444,533Alexander H. Stegh · Washington University · R01 · FY2024 · CA
Project 2: Deciphering the Dynamic Evolution of the Tumor-Immune Interface
$444,255Stefani Spranger · Massachusetts Institute Of Technology · U54 · FY2025 · CA
Patterned optogenetic neuromodulation to reprogram glioma stem cells
$444,125Robert C Rostomily · Methodist Hospital Research Institute · R21 · FY2024 · NS
Radiogenomics framework for non-invasive personalized medicine
$444,001Olivier Gevaert · Stanford University · R56 · FY2019 · EB
Delineating microglial NF-kappaB signaling in glioblastoma growth and therapy
$443,996Jennifer Webster Bradford · Augusta University · R15 · FY2019 · NS
Mechanism of regulation of progenitor proliferation and transformation
$443,782Patrizia Casaccia · Advanced Science Research Center · R01 · FY2017 · NS
Hematopoietic Chemoprotection in Glioblastoma Patients
$443,776Hans-Peter Kiem · Fred Hutchinson Cancer Research Center · R01 · FY2008 · CA
Identification and modeling of driver genetic modules in glioblastoma
$443,694Antonio Iavarone · Columbia University Health Sciences · R01 · FY2018 · CA
Immune-suppressive Myeloid Cells in the Glioma Microenvironment: Signaling Mechanisms and Novel Therapeutic Strategies
$443,645Maria G Castro · University Of Michigan At Ann Arbor · R37 · FY2021 · NS
Immune-suppressive Myeloid Cells in the Glioma Microenvironment: Signaling Mechanisms and Novel Therapeutic Strategies
$443,645Maria G Castro · University Of Michigan At Ann Arbor · R37 · FY2019 · NS
Immune-suppressive Myeloid Cells in the Glioma Microenvironment: Signaling Mechanisms and Novel Therapeutic Strategies
$443,645Maria G Castro · University Of Michigan At Ann Arbor · R37 · FY2020 · NS
The Role of Cellular Receptors Involved in Inflammation and Tumor Progression
$443,620Ji Ming Wang · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Novel L-threo-sphinganines for ceramides-based cancer therapy
$443,579Barry J Maurer · Texas Tech University Health Scis Center · R15 · FY2012 · CA
Immobilized Drug Transporters
$443,566Irving William Wainer · National Institute On Aging · ZIA · FY2011 · AG
Spherical Nucleic Acid nano-architectures as first-in-class cGAS agonists for the immunotherapeutic treatment of Glioblastoma.
$443,482Alexander H. Stegh · Washington University · R01 · FY2022 · CA
A Pathway of Tumor Suppression
$443,233Guillermina Lozano · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Monoclonal Antibody to FGF2 for Treatment of Hepatocellular Carcinoma and Other C
$443,212K Jin Kim · Galaxy Biotech, Llc · R44 · FY2011 · CA
Mechanisms underlying BAI1/ADGRB1 negative regulation of glioblastoma mesenchymal transition and invasion.
$442,928Erwin G Van Meir · University Of Alabama At Birmingham · R01 · FY2021 · NS
Mechanisms underlying BAI1/ADGRB1 negative regulation of glioblastoma mesenchymal transition and invasion.
$442,928Erwin G Van Meir · University Of Alabama At Birmingham · R01 · FY2022 · NS
Therapeutic Targeting of WDR5 in the Glioblastoma Perivascular Niche
$442,887Christopher G Hubert · Case Western Reserve University · R01 · FY2024 · NS
Transcriptional Control of Human Cytomegalovirus Latency
$442,788Robert F Kalejta · University Of Wisconsin-Madison · R01 · FY2025 · AI
Immobilized Drug Transporters
$442,785Irving William Wainer · National Institute On Aging · ZIA · FY2013 · AG
Is Low Tumor Mutational Burden Predictive of Response to Oncolytic Polio Virus Therapy in Recurrent Glioblastoma?
$442,750David M. Ashley · Duke University · R21 · FY2019 · NS
Induce and Image extrachromosomal DNA in human glioblastoma avatar
$442,750Liangqi Xie · Cleveland Clinic Lerner Com-Cwru · R21 · FY2025 · NS